Kidney Cancer Cases

Case 1: Light cell kidney adenocarcinoma pathology with metastasis

Name: Jorge Lindh
Age: 56 years old
Country: Sweden
Reason of consultation:
11/21/2001 Left nefrectomized patient in 1998 by a malignant kidney pathology. He underwent surgery in Sweden, resulting a light cell adenocarcinoma.
Personal antecedents:
No antecedents to remark.
Family antecedents:
We ignore them.
Present disease antecedents:
It was thought at the first place that the neoplasy had been taken definitively, a year later, after two checkings that did not show any anomaly, shortly after the third checking, in July, 2001, he had a thorax additional tomography. At that moment metastasis in both lungs were discovered. Lymphatic metastasis in left and right lung which oppress both the tracheas and the esophagus. Later on it was discovered an additional metastasis in the left kidney post-surgery lay and behind the right clavicle. He consults about the possibility of treating himself with our medicament.
11/21/2001 The treatment is initiated with 30 drops 4 times per day of the medicament, for fifteen days, then 40 drops 4 times per day.
Disease evolution:
Patient who was treated only with our medicament by his own will.
01/27/2002 He expresses well being due to the intake of the medicament. He does not have swallowing difficulties because of the compression that the metastasis from both lungs made on the esophagus and the tracheas.
02/28/2002 The metastasis on the left kidney surgery lay has stopped its growth.
The metastasis behind right clavicle also stopped its growth.
The lungs metastasis which oppressed tracheas and esophagus only have grown 10,14 mm, he does not have swallowing difficulties.
03/14/2002 He comes to consult in Montevideo, subjectively and objectively well.
He maintained his weight. Normal kidney functionality. Marginal tumor growth, it is increased to 50 drops 4 times per day.
The patient improves his life quality, he can perform a normal life ambulatory, he goes on with 50 drops 4 times per day having his next control in May.
He is asymptomatic in clinic cure and is released with a maintenance GREEN SAP dosage.
Conclusions:
Patient of 56 years old, left kidnectomized in 1998 due to a malignant kidney pathology (light cell kidney adenocarcinoma), surgery in Sweden. In July, 2001, there were metastasis discovered by thorax tomography, in both lungs. Lymphatic metastasis in left and right lung. Metastasis which oppress both the tracheas and the esophagus. Later on it was discovered an additional metastasis in the left kidney post-surgery lay and another one behind the right clavicle.
11/21/2001: He initiates the treatment with 30 drips 4 times per day. He begins with evident improvement, corroborated by exams. He received only GREEN SAP treatment, by his own will. He improves his swallowing capability. He improves his breathing capacity. Very good general state.
03/14/2002: He comes to Montevideo, subjectively and objectively fine. There are no doubts left about the beneficial action to a great level of GREEN SAP medicament, as the patient is in clinic cure and on release. It is doubtless that the medication has had a remarkable anti-tumor effect, with characteristics that equals the most ancient and experienced drugs by other colleagues. GREEN SAP action is not accidentally as we mentioned in GREEN SAP Action on kidney neoplasies (see page 89). This action was observed throughout the years and the experience that is given by its use, which also fills with satisfaction both us and the people who use it.

Case 2: Light cell adenocarcinoma and hypernefroma

Name: Jorge Antonio Suárez
Age: 51 years old
Country: Argentina
Reason of consultation:
12/27/2001 Left kidnectomized in 1994 due to hypernefroma.
Asymptomatic until March, 2001.
Personal antecedents:
No personal antecedents to remark.
Family antecedents:
No family antecedents to remark.
Present disease antecedents:
Asymptomatic patient until March, 2001 when he presents a left iliac fossa tumor, he has a biopsy done which shows a light cell carcinoma.
Clinically asymptomatic.
Computerized tomography: right supra-kidney gland metastasis. Nodular lesion in contact with the posterior side of the lower cava vein. Nodular lesions that compromise the psoas muscle.
He had a computerized tomography of the facial cranium structure done, which was normal.
Neck computerized tomography: normal.
Thorax computerized tomography: nodular image of soft parts density of approximately 15 mm in maximum left posterior intercostals diameter which would have to be evaluated following the antecedents.
Pelvic abdominal computerized tomography: it were explored the pelvic and abdominal regions, after the intake of oral contrast substance to dye the digestive tube and the injection of contrast substances intravenously.
Discrete diffuse hypo-density of the liver parenchyma compatible with slight infiltration. Nodular images compatible with metastasis in the right supra-kidney gland. The biggest of them of approximately 35 mm. It is also observed nodular lesion in contact with the lateral side of the lower cava vein immediately above the right kidney vein. Sequel of left kidnectomy, being identified the pancreas tail and the lower pole of the spleen at the kidney fosse. It is observed nodular lesion in the upper pole of the right kidney. The gall bladder does not show any alteration. The left supra-kidney gland is not identifiable. Nodular lesion with cystic and/or necrotic center coming from the front area of the left psoas muscle. It can also be observed nodular confluent lesions with soft parts density which involve the left iliac psoas muscle. It is also identified a nodular lesion in the right internal obturator muscle.
Comment: The described lesions in the thorax and specially in the abdominal-pelvic region are compatible in first place with metastasis.

Disease evolution:
He initiated the treatment with the medicament in November, 2001, with 45 drops 4 times per day. After a month he continued with 50 drops. Next month 60 drops 4 times per day.
04/03/2002: Clinically asymptomatic. Kidney carcinoma Stage IV. Tomographic improvement of his lesions in February, 2002.
He goes on with 60 drops every 6 hours sublingually.
08/28/2002: Patient stable, he keeps on asymptomatic and with good survival. He performs daily activities. He feeds well. He sleeps well. Conserved digestive transit. Urinary transit: no major alterations.
04/11/2003: In clinic cure, on release with maintenance GREEN SAP dosage.

Conclusions:
Patient of 51 years old, left kidnectomized. Asymptomatic, until March, 2001. In March, 2001 presents a left iliac fosse tumor which shows in the biopsy Light Cell Carcinoma. He also presents in the computerized tomography a nodular image with soft parts density of 15 mm. of intercostals maximum diameter.
Lesions compatible with metastasis in the right supra-kidney gland.
He initiated treatment whit the medicament in November, 2001, quickly evolutioning both clinic and imagenologically.
The GREEN SAP’ mechanism of action on the kidney tumors and its metastasis manifested once more leading the patient to the clinic cure and his release. Maintaining a control dosage with the medicament.
This patient is in healthy state, what we attribute to the use of GREEN SAP, which has acted as we have been seen for years, in an excellent way. GREEN SAP is a therapeutic weapon of first level and our patients are our witnesses of the seriousness with what we face our work with them and we believe that this medicament is a fundamental contribution to the contemporary medicine.

Case 3: Kidney cancer

Name: Irma Renoldi
Age: 65 years old
Country: Argentina
Reason of consultation:
03/19/2002 She consults due to retro-peritoneal tumoration.
Personal antecedents:
Without personal antecedents to remark.
Family antecedents:
None to remark.
Present disease antecedents:
She begins with lower limbs edema a month ago reason why she underwent exams. The abdominal ultrasonography and abdominal-pelvic and thoracic CAT show a left kidney mass. The CAT informs retroperitoneal mass that measures 5,1 cm. That seems to originate in the back valve of the left upper pole extending to the medial area getting in touch with the diaphragm and also with the left kidney vein. The bone centellogram does not show metastasis. The treatment with the medicament is initiated taking 40 drops 4 times per day.
Disease evolution:
06/05/2002 – Clinic and paraclinic improvement. Awaiting new paraclinic studies. Anyway the improvement of the patient’s life quality is impressive. She goes on with 40 drops 4 times per day.
08/21/2002 - She comes to consult. She does not bring CAT but confirms us complete reducing of the tumor mass. Asymptomatic.
We maintain 40 drops 4 times per day sublingually. We maintain such dosage until December, 2002.
At the present moment, due to the complete reducing of the tumor mass and the excellent clinic and paraclinic state we release her with proved clinic cure, maintaining basal dosage of the medicament during a month, once a year.
Conclusions:
Patient of 65 years old, who consults because of a retroperitoneal tumoration. The CAT shows retroperitoneal mass which measures 5,1 cm., that seems to originate in the back valve of the left upper pole, extending to the medial sector getting in touch with the diaphragm and also with the sub-renal gland. It also contacts the kidney vein.
She initiates the treatment taking 40 drops 4 times per day. GREEN SAP, due to the explained mechanisms in the kidney anti-tumor action, acted in a quick and effective way, achieving the patient’s clinic cure and her release, who presented a voluminous and related to other structures in the vicinity, kidney tumor.
GREEN SAP stopped the tumor kinetic, leading the patient towards a healthy state that more expensive medicaments and with more disgusting collateral effects and medicament interactions do not achieve in a indolent way, that is without suffering as our medicament does which has the back up of the cases in which it has achieved complete remissions, clinic cures and over all, what more interests us, an excellent life quality that allows the patient to develop from a physical point of view in a completely normal way, what psychologically benefits him in a superlative way, this being many times forgotten by the traditional medicine, but we keep in mind every day focusing the patient as a whole.
GREEN SAP deserves a stand up position among the medications which fight malignant diseases and make so without causing collateral effects, which many times in traditional medicine oblige to give up the treatment, which in a very high percentage of cases this does not happen to us, also establishing through GREEN SAP an actual friendship with the patient, what encourages him to go on and achieve the cure as in this case, in which this medication was used.